Commodore Capital LP

Holdings History for Enliven Therapeutics, Inc. - Common Stock, $0.001 par value per share (ELVN)

Symbol: ELVN on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share
Latest Disclosed Shares Owned: 6,022,957 shares
Security Ownership %: 9.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Commodore Capital LP ownership in Enliven Therapeutics, Inc. Common Stock, $0.001 par value per share (ELVN)

14 Aug 2025 - Commodore Capital LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,022,957 shares of Enliven Therapeutics, Inc. Common Stock, $0.001 par value per share (ELVN). This represents 9.9% ownership of the company. This is the first filing by Commodore Capital LP disclosing ownership of Enliven Therapeutics, Inc. Common Stock, $0.001 par value per share (ELVN).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Commodore Capital LP	9.9%		$124,554,751	6,022,957			$20.68	13G/A	30 Jun 2025	14 Aug 2025, 17:06

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	4.7%	0%	$96,061,800	4,692,809	0		$20.47	Q3 2025
30 Jun 2025	6.6%	+0.03%	$94,137,749	4,692,809	+17,809	+0.38%	$20.06	Q2 2025
31 Mar 2025	6.8%	+0.68%	$92,004,000	4,675,000	+470,000		$19.68	Q1 2025
31 Dec 2024	6.9%	+0.17%	$94,612,500	4,205,000	+105,000	+2.6%	$22.50	Q4 2024
30 Sep 2024	6.5%	+0.2%	$104,714,000	4,100,000	+126,755	+3.2%	$25.54	Q3 2024
30 Jun 2024	6.3%	0%	$92,854,736	3,973,245	0		$23.37	Q2 2024
31 Mar 2024	4.7%	+1.6%	$69,889,380	3,973,245	+1,071,429	+37%	$17.59	Q1 2024
31 Dec 2023	3.5%	0%	$40,161,133	2,901,816	0		$13.84	Q4 2023
30 Sep 2023	4.6%	+0.9%	$39,638,807	2,901,816	+553,544	+24%	$13.66	Q3 2023
30 Jun 2023	5.4%	+1.4%	$47,928,232	2,348,272	+616,907	+36%	$20.41	Q2 2023
31 Mar 2023	5.8%	+5.8%	$37,916,894	1,731,365	+1,731,365	NEW	$21.90	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.